IGM Biosciences, Inc. Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
IGM Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • IGM Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$51.4M, a 24.7% increase year-over-year.
  • IGM Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$237M, a 4.54% increase year-over-year.
  • IGM Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$263M, a 15.6% decline from 2022.
  • IGM Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$228M, a 37.9% decline from 2021.
  • IGM Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$165M, a 98.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$263M -$35.5M -15.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$228M -$62.6M -37.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$165M -$82M -98.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-07
2020 -$83.3M -$38.8M -87.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-30
2019 -$44.5M -$21.7M -95.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
2018 -$22.8M -$11.6M -104% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
2017 -$11.1M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.